menu
    • menu

    Company profile for Propanc Biopharma

    NEW Drugs in Dev: 1
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Propanc Biopharma, Inc. is a clinical stage biopharmaceutical company focused on developing new cancer treatments for patients suffering from pancreatic, ovarian and colorectal cancers. Together with our scientific and oncology consultants, we have developed a rational, composite formulation of anti-cancer compounds, which together exert a number of effects designed to control or prevent tumors from recurring and spreading thr...
    Propanc Biopharma, Inc. is a clinical stage biopharmaceutical company focused on developing new cancer treatments for patients suffering from pancreatic, ovarian and colorectal cancers. Together with our scientific and oncology consultants, we have developed a rational, composite formulation of anti-cancer compounds, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Propanc BiopharmaAustralia Flag
    Country
    Country
    Australia
    Address
    Address
    302/6 Butler Street Camberwell, VIC 3124
    Telephone
    Telephone
    +61 (0)3 9882 0780
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.propanc.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Propanc Pharma Inks Anti-Aging, Cancer Deal in Jaén, Granada
    Propanc Pharma Inks Anti-Aging, Cancer Deal in Jaén, Granada

    24 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/24/3261252/0/en/Propanc-Biopharma-Executes-Multi-Yr-Anti-Aging-Cancer-Research-Collaboration-with-the-Universities-of-Ja%C3%A9n-and-Granada-Spain.html

    GLOBENEWSWIRE
    24 Mar 2026
    Share Share
    Propanc Pharma Targets $3B+ Pancreatic Cancer Market With PRP
    Propanc Pharma Targets $3B+ Pancreatic Cancer Market With PRP

    12 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/12/3254682/0/en/Propanc-Biopharma-Targets-3B-Pancreatic-Cancer-Market-with-PRP-85-Tumor-Inhibition-in-Breakthrough-Proenzyme-Therapy.html

    GLOBENEWSWIRE
    12 Mar 2026
    Share Share
    Propanc Bio Partners Fyonibio For Phase 1B Pk Assay Validation
    Propanc Bio Partners Fyonibio For Phase 1B Pk Assay Validation

    10 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/10/3252839/0/en/Propanc-Biopharma-Executes-Service-Agreement-with-FyoniBio-to-Establish-Validate-Pharmacokinetics-Assay-for-Phase-1b-First-In-Human-Study.html

    GLOBENEWSWIRE
    10 Mar 2026
    Share Share
    Propanc Bio's PRP Achieves >85% Tumor Growth Inhibition in Model
    Propanc Bio's PRP Achieves >85% Tumor Growth Inhibition in Model

    03 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/03/3248396/0/en/Propanc-Biopharma-s-Lead-Asset-PRP-Shows-85-Tumor-Growth-Inhibition-in-Preclinical-Pancreatic-Models.html

    GLOBENEWSWIRE
    03 Mar 2026
    Share Share
    Propanc Unveils PRP Proenzyme Therapy Targeting Pancreatic Cancer
    Propanc Unveils PRP Proenzyme Therapy Targeting Pancreatic Cancer

    05 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/05/3233021/0/en/Propanc-Biopharma-Unveils-PRP-A-Game-Changing-Proenzyme-Therapy-Poised-to-Challenge-Standard-Cancer-Treatments-in-the-3-Billion-Pancreatic-Cancer-Market.html

    GLOBENEWSWIRE
    05 Feb 2026
    Share Share
    Propanc Biopharma Files 4th Provisional Patent in 2 Months
    Propanc Biopharma Files 4th Provisional Patent in 2 Months

    27 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/27/3226520/0/en/Propanc-Biopharma-Accelerates-IP-Momentum-Files-Fourth-Provisional-Patent-Application-in-Just-Two-Months-Strengthening-Global-Protection-for-Breakthrough-Proenzyme-Formulations.html

    GLOBENEWSWIRE
    27 Jan 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search